Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoic acid | Human immunodeficiency virus 1 | IC50 | 0.2700 | 1 | 0 |
thioctic acid | Human immunodeficiency virus 1 | IC50 | 7.6700 | 1 | 0 |
tryptamine | Human immunodeficiency virus 1 | IC50 | 1.6600 | 1 | 0 |
5,8,11,14-eicosatetraynoic acid | Human immunodeficiency virus 1 | IC50 | 0.8600 | 1 | 0 |
doxorubicin hydrochloride | Human immunodeficiency virus 1 | IC50 | 49.1800 | 1 | 0 |
ppm 18 | Human immunodeficiency virus 1 | IC50 | 20.7200 | 1 | 0 |
streptonigrin | Human immunodeficiency virus 1 | IC50 | 10.8200 | 1 | 0 |
7-amino-4-hydroxy-2-naphthalenesulfonic acid | Human immunodeficiency virus 1 | IC50 | 9.4400 | 1 | 0 |
n-isopropyl-n-phenyl-4-phenylenediamine | Human immunodeficiency virus 1 | IC50 | 9.1800 | 1 | 0 |
5-amino-2-naphthalenesulfonate | Human immunodeficiency virus 1 | IC50 | 35.0100 | 1 | 0 |
hematoxylin | Human immunodeficiency virus 1 | IC50 | 0.4600 | 1 | 0 |
1,2-naphthoquinone | Human immunodeficiency virus 1 | IC50 | 10.6100 | 1 | 0 |
nitroxoline | Human immunodeficiency virus 1 | IC50 | 46.5300 | 1 | 0 |
benserazide hydrochloride | Human immunodeficiency virus 1 | IC50 | 1.4900 | 1 | 0 |
Nanaomycin | Human immunodeficiency virus 1 | IC50 | 4.1600 | 1 | 0 |
2,2'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)diimino)bis-benzoic acid | Human immunodeficiency virus 1 | IC50 | 0.9400 | 1 | 0 |
methyl fluorone black | Human immunodeficiency virus 1 | IC50 | 0.6100 | 1 | 0 |
9-hydroxyphenylfluoron | Human immunodeficiency virus 1 | IC50 | 0.8400 | 1 | 0 |
2-(4-hydroxyphenyl)-5,6,7,8-tetrahydroxy-4H-1-benzopyran-4-one | Human immunodeficiency virus 1 | IC50 | 22.1400 | 1 | 0 |
4-chloro-3-(2,4-dihydroxyphenylazo)-2-hydroxybenzene-1-sulfonic acid | Human immunodeficiency virus 1 | IC50 | 49.4400 | 1 | 0 |
3,3'-Dihydroxyhexestrol | Human immunodeficiency virus 1 | IC50 | 6.4600 | 1 | 0 |
variamycin | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 0 |
tryptoline | Human immunodeficiency virus 1 | IC50 | 84.2500 | 1 | 0 |
sch 45752 | Human immunodeficiency virus 1 | IC50 | 0.4100 | 1 | 0 |
raubasine | Human immunodeficiency virus 1 | IC50 | 17.9500 | 1 | 0 |
nsc 74859 | Human immunodeficiency virus 1 | IC50 | 64.0600 | 1 | 0 |
Poriol | Human immunodeficiency virus 1 | IC50 | 2.6800 | 1 | 0 |
hematoxylin | Human immunodeficiency virus 1 | IC50 | 0.5700 | 1 | 0 |
(R)-norlaudanosoline | Human immunodeficiency virus 1 | IC50 | 9.7700 | 1 | 0 |
resveratrol | Human immunodeficiency virus 1 | IC50 | 25.3100 | 1 | 0 |
3-methyl-4-(7-methyl-2-indolizinyl)-1,2,5-oxadiazole | Human immunodeficiency virus 1 | IC50 | 22.4700 | 1 | 0 |
4-methoxy-1,3-dimethyl-6-thiophen-2-yl-8-cyclohepta[c]furanone | Human immunodeficiency virus 1 | IC50 | 3.5500 | 1 | 0 |
1-[4-[4-[(phenylmethyl)amino]phenyl]-1-piperazinyl]ethanone | Human immunodeficiency virus 1 | IC50 | 50.5150 | 1 | 0 |
4,5-dimethyl-2-[[oxo(thiophen-2-yl)methyl]amino]-3-thiophenecarboxylic acid ethyl ester | Human immunodeficiency virus 1 | IC50 | 32.8600 | 1 | 0 |
3-fluoro-N-[1-[2-[(2-fluorophenyl)methylamino]-2-oxoethyl]-4-piperidinyl]benzamide | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 0 |
N-[2-[1,3-benzodioxol-5-yl-[2-(tert-butylamino)-2-oxo-1-pyridin-4-ylethyl]amino]-2-oxoethyl]-2-furancarboxamide | Human immunodeficiency virus 1 | IC50 | 11.2600 | 1 | 0 |
1-(4,6-dimethyl-2-pyrimidinyl)-4-piperidinecarboxylic acid | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 0 |
5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 0 |
2-cyano-N-(2-furanylmethyl)-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetamide | Human immunodeficiency virus 1 | IC50 | 51.6600 | 1 | 0 |
2-[(4-amino-5-cyclohexyl-1,2,4-triazol-3-yl)thio]-N-(3-fluoro-4-methylphenyl)acetamide | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 0 |
(3aR,6aS)-3-(2-chlorophenyl)-5-(2,5-dimethoxyphenyl)-3a,6a-dihydropyrrolo[3,4-d]isoxazole-4,6-dione | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 0 |
(3,4-dimethylphenyl)-(4-phenyl-1-piperazinyl)methanone | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 0 |
N-[4-(diethylamino)phenyl]-2-furancarboxamide | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 0 |
2-(1H-benzimidazol-2-ylthio)-1-(2,3-dimethyl-1-indolyl)ethanone | Human immunodeficiency virus 1 | IC50 | 39.7000 | 1 | 0 |
2-hydroxy-5-[[(5-methyl-2-furanyl)-oxomethyl]amino]benzoic acid | Human immunodeficiency virus 1 | IC50 | 3.8700 | 1 | 0 |
2-[[cyclopentyl(oxo)methyl]amino]benzoic acid methyl ester | Human immunodeficiency virus 1 | IC50 | 0.5500 | 1 | 0 |
3-[5-(2-furanyl)-1H-pyrazol-3-yl]-4-(2-methoxyphenyl)-1H-1,2,4-triazole-5-thione | Human immunodeficiency virus 1 | IC50 | 3.1100 | 1 | 0 |
7-chloro-2,3-dihydro-1H-cyclopenta[b]quinoline-9-carboxylic acid | Human immunodeficiency virus 1 | IC50 | 23.4200 | 1 | 0 |
10-(4-methoxyphenyl)-3,4,5,6,7,9-hexahydro-2H-acridine-1,8-dione | Human immunodeficiency virus 1 | IC50 | 26.3200 | 1 | 0 |
2-[[2-[(4-chlorophenyl)thio]-1-oxoethyl]amino]-N-(4-methoxyphenyl)benzamide | Human immunodeficiency virus 1 | IC50 | 57.6900 | 1 | 0 |
7-anilino-3-(4-bromophenyl)-5-(4-morpholinyl)-1,4-thiazepine-6-carbonitrile | Human immunodeficiency virus 1 | IC50 | 97.1300 | 1 | 0 |
5-bromo-N-(2-fluorophenyl)-6-oxo-3-pyrancarboxamide | Human immunodeficiency virus 1 | IC50 | 7.0600 | 1 | 0 |
4-(2-bromo-4-methylphenyl)-3-[5-(2-furanyl)-1H-pyrazol-3-yl]-1H-1,2,4-triazole-5-thione | Human immunodeficiency virus 1 | IC50 | 6.3900 | 1 | 0 |
2-[3-(2-furanylmethyl)-2,4-dioxo-6,7,8,9-tetrahydro-5H-cyclohepta[2,3]thieno[2,4-b]pyrimidin-1-yl]acetamide | Human immunodeficiency virus 1 | IC50 | 3.8000 | 1 | 0 |
N-[4-(dibutylsulfamoyl)phenyl]-2-thiophen-2-ylacetamide | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 0 |
1-[4-(4-hydroxyphenyl)-1-piperazinyl]-3-(1H-indol-3-yl)-1-propanone | Human immunodeficiency virus 1 | IC50 | 13.3100 | 1 | 0 |
N-(1,5-dimethyl-3-oxo-2-phenyl-4-pyrazolyl)-2-[4-(4-hydroxyphenyl)-1-piperazinyl]acetamide | Human immunodeficiency virus 1 | IC50 | 10.1800 | 1 | 0 |
5-cyclopentylidene-2-sulfanylidene-4-thiazolidinone | Human immunodeficiency virus 1 | IC50 | 6.2000 | 1 | 0 |
2,5-dimethoxy-n-(quinolin-3-yl)benzenesulfonamide | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 0 |
1-[4-(dimethylamino)phenyl]-3-[4-(4-morpholinyl)anilino]pyrrolidine-2,5-dione | Human immunodeficiency virus 1 | IC50 | 1.2300 | 1 | 0 |
4-[[[4-(2-furanylmethyl)-5-(thiophen-2-ylmethyl)-1,2,4-triazol-3-yl]thio]methyl]benzonitrile | Human immunodeficiency virus 1 | IC50 | 46.5500 | 1 | 0 |
3-(3,4-dihydro-2H-quinolin-1-ylmethyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine | Human immunodeficiency virus 1 | IC50 | 31.5100 | 1 | 0 |
2-(2-furanyl)-N-(2-oxolanylmethyl)-4-quinolinecarboxamide | Human immunodeficiency virus 1 | IC50 | 14.3600 | 1 | 0 |
2-(4-ethoxy-3-methoxyphenyl)-4-mercapto-3-(4-methoxyphenyl)-6-oxo-1,2-dihydropyrimidine-5-carbonitrile | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 0 |
4-[4-[[1-(2-methylbutan-2-yl)-5-tetrazolyl]-(6-quinolinyl)methyl]-1-piperazinyl]phenol | Human immunodeficiency virus 1 | IC50 | 4.6500 | 1 | 0 |
4-(2-furanyl)-N-(3-pyridinylmethyl)-6-(trifluoromethyl)-2-pyrimidinamine | Human immunodeficiency virus 1 | IC50 | 42.3200 | 1 | 0 |
2-(7-methyl-4-oxo-3-furo[3,4]pyrrolo[3,5-c][1,2,4]triazinyl)acetic acid methyl ester | Human immunodeficiency virus 1 | IC50 | 71.6300 | 1 | 0 |
2-amino-7-methyl-4-(5-nitro-2-furanyl)-5-oxo-4H-pyrano[3,2-c]pyran-3-carbonitrile | Human immunodeficiency virus 1 | IC50 | 2.5300 | 1 | 0 |
3-(3,5-dimethylanilino)-5-(2-furanyl)-1-cyclohex-2-enone | Human immunodeficiency virus 1 | IC50 | 60.6750 | 1 | 0 |
2-[1-[4-(diethylamino)phenyl]-4a-hydroxy-1,3,4,5,6,7,8,8a-octahydroisoquinolin-2-yl]-N-phenylacetamide | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 0 |
isovitexin | Human immunodeficiency virus 1 | IC50 | 7.0500 | 1 | 0 |
4-chloro-N-[3-(N-methylanilino)-1,4-dioxo-2-naphthalenyl]benzamide | Human immunodeficiency virus 1 | IC50 | 52.3600 | 1 | 0 |
4-[3-(2-chloro-1-oxoethyl)-2,5-dimethyl-1-pyrrolyl]-1,5-dimethyl-2-phenyl-3-pyrazolone | Human immunodeficiency virus 1 | IC50 | 42.8000 | 1 | 0 |
ellagic acid | Human immunodeficiency virus 1 | IC50 | 0.4500 | 1 | 0 |
3-[[4-[6-(4-morpholinyl)-3-pyridazinyl]-1-piperazinyl]-oxomethyl]-1-benzopyran-2-one | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 0 |
6-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-3-ethyl-1H-pyrimidine-2,4-dione | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 0 |
N-[(3-methyl-6-imidazo[2,1-b]thiazolyl)methyl]-1-propanesulfonamide | Human immunodeficiency virus 1 | IC50 | 100.0000 | 1 | 0 |
erbstatin | Human immunodeficiency virus 1 | IC50 | 1.7200 | 1 | 0 |
3,3'-diethylthiatricarbocyanine iodide, 3h-labeled | Human immunodeficiency virus 1 | IC50 | 4.3300 | 1 | 0 |
1,5-anhydro-1-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-6-yl]hexitol | Human immunodeficiency virus 1 | IC50 | 12.6600 | 1 | 0 |
epinephrine bitartrate | Human immunodeficiency virus 1 | IC50 | 1.1600 | 1 | 0 |
5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-3-yl 6-O-(6-deoxyhexopyranosyl)hexopyranoside | Human immunodeficiency virus 1 | IC50 | 11.8100 | 1 | 0 |
violaceol II | Human immunodeficiency virus 1 | IC50 | 13.7700 | 1 | 0 |
lomofungin | Human immunodeficiency virus 1 | IC50 | 0.3500 | 1 | 0 |
galloflavin | Human immunodeficiency virus 1 | IC50 | 1.6800 | 1 | 0 |